Labyrinth Capital Partners takes ‘rifle-shot’ approach to GP-led secondaries

The growth-stage secondaries specialist, which is premarketing a $300m Fund III, draws on its founder's 20 years of experience to provide liquidity to GPs thirsty for DPI.